| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
SureSwab®, Herpes Simplex Virus, Type 1 and 2 mRNA, TMA
Test Code90570
CPT Codes
87529 (x2)
Preferred Specimen
1 male or female anogenital lesion swab collected in APTIMA® Vaginal Collection Kit or Multi-Test Collection Kit (orange label)
Instructions
Follow the instructions provided in the APTIMA® Vaginal Collection Kit or Multi-Test Collection Kit (orange label). Remove the swab from the packaging and swab any visible lesions. Withdraw the swab without touching the skin. Immediately place the swab into the transport tube so that the tip of the swab is visible below the tube label. Carefully break the swab shaft at the score line against the side of the tube and discard the top portion of the swab shaft. Tightly screw the cap onto the tube.
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 36 days
Refrigerated: 36 days
Frozen: 36 days
Refrigerated: 36 days
Frozen: 36 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Non APTIMA® Collection Kit • Aptima® Unisex Collection Kit (white label) • Leaking samples • Uncapped samples • Broken container
Methodology
Transcription-Mediated Amplification (TMA)
Setup Schedule
Set up: Daily; Report available: 2 days
Reference Range
| HSV 1 | Not detected |
| HSV 2 | Not detected |
Clinical Significance
The SureSwab®, HSV Type 1/2 mRNA, TMA assay is intended for use as an aid in the diagnosis of HSV-1 and/or HSV-2 infections in symptomatic male and female patients. The assay is not validated for cerebral spinal fluid samples or for use in prenatal screening.
Performing Laboratory
| Quest Diagnostics Nichols Institute |
| 14225 Newbrook Drive |
| Chantilly, VA 20153 |
